Industry Research Reports

Home > Reports > Service & Software > Anti-Infective Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Anti-Infective Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Service & Software

Published Date: 2024-01-24

Pages: 132 Pages

Report ld: 2342000

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Anti-Infective Drugs Market Size(US$)

CAGR 2024-2030

3.4%

Market Size,2030

USD 272,130

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 222,660 million

Market Forecast in 2030(Value)

US$ 272,130 million

CAGR

3.4%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.

The global market for Anti-Infective Drugs was estimated to be worth US$ 215340 million in 2023 and is forecast to a readjusted size of US$ 272130 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030

The Anti-Infective Drugs market refers to the pharmaceuticals and medications used for the treatment of infectious diseases caused by bacteria, viruses, fungi, or parasites. This market encompasses various therapeutic areas such as antibiotics, antivirals, antifungals, and antiparasitics. The Anti-Infective Drugs market has been witnessing steady growth due to factors such as the increasing prevalence of infectious diseases, the emergence of drug-resistant strains, and the growing global population. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America currently holds a significant market share, but the market in Asia Pacific is expected to witness substantial growth in the coming years.

MARKET SEGMENTATION

By Company

GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

OTC
Rx Drugs

Segment by Application

Hospital
Drugs Store
Other

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Anti-Infective Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Anti-Infective Drugs by region & country, by Type, and by Application.

The Anti-Infective Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Infective Drugs.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Anti-Infective Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Anti-Infective Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Anti-Infective Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Anti-Infective Drugs Product Introduction

1.2 Global Anti-Infective Drugs Market Size Forecast

1.3 Anti-Infective Drugs Market Trends & Drivers

1.3.1 Anti-Infective Drugs Industry Trends

1.3.2 Anti-Infective Drugs Market Drivers & Opportunity

1.3.3 Anti-Infective Drugs Market Challenges

1.3.4 Anti-Infective Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Anti-Infective Drugs Players Revenue Ranking (2023)

2.2 Global Anti-Infective Drugs Revenue by Company (2019-2024)

2.3 Key Companies Anti-Infective Drugs Manufacturing Base Distribution and Headquarters

2.4 Key Companies Anti-Infective Drugs Product Offered

2.5 Key Companies Time to Begin Mass Production of Anti-Infective Drugs

2.6 Anti-Infective Drugs Market Competitive Analysis

2.6.1 Anti-Infective Drugs Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Anti-Infective Drugs Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Drugs as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 OTC

3.1.2 Rx Drugs

3.2 Global Anti-Infective Drugs Sales Value by Type

3.2.1 Global Anti-Infective Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Anti-Infective Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Anti-Infective Drugs Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Drugs Store

4.1.3 Other

4.2 Global Anti-Infective Drugs Sales Value by Application

4.2.1 Global Anti-Infective Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Anti-Infective Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Anti-Infective Drugs Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Anti-Infective Drugs Sales Value by Region

5.1.1 Global Anti-Infective Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Anti-Infective Drugs Sales Value by Region (2019-2024)

5.1.3 Global Anti-Infective Drugs Sales Value by Region (2025-2030)

5.1.4 Global Anti-Infective Drugs Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Anti-Infective Drugs Sales Value, 2019-2030

5.2.2 North America Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Anti-Infective Drugs Sales Value, 2019-2030

5.3.2 Europe Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Anti-Infective Drugs Sales Value, 2019-2030

5.4.2 Asia Pacific Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Anti-Infective Drugs Sales Value, 2019-2030

5.5.2 South America Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Anti-Infective Drugs Sales Value, 2019-2030

5.6.2 Middle East & Africa Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Anti-Infective Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Anti-Infective Drugs Sales Value

6.3 United States

6.3.1 United States Anti-Infective Drugs Sales Value, 2019-2030

6.3.2 United States Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Anti-Infective Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Anti-Infective Drugs Sales Value, 2019-2030

6.4.2 Europe Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Anti-Infective Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Anti-Infective Drugs Sales Value, 2019-2030

6.5.2 China Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Anti-Infective Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Anti-Infective Drugs Sales Value, 2019-2030

6.6.2 Japan Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Anti-Infective Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Anti-Infective Drugs Sales Value, 2019-2030

6.7.2 South Korea Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Anti-Infective Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Anti-Infective Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Anti-Infective Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Anti-Infective Drugs Sales Value, 2019-2030

6.9.2 India Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Anti-Infective Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 GlaxoSmithKline

7.1.1 GlaxoSmithKline Profile

7.1.2 GlaxoSmithKline Main Business

7.1.3 GlaxoSmithKline Anti-Infective Drugs Products, Services and Solutions

7.1.4 GlaxoSmithKline Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.1.5 GlaxoSmithKline Recent Developments

7.2 Merck

7.2.1 Merck Profile

7.2.2 Merck Main Business

7.2.3 Merck Anti-Infective Drugs Products, Services and Solutions

7.2.4 Merck Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.2.5 Merck Recent Developments

7.3 Pfizer

7.3.1 Pfizer Profile

7.3.2 Pfizer Main Business

7.3.3 Pfizer Anti-Infective Drugs Products, Services and Solutions

7.3.4 Pfizer Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.3.5 Novartis AG Recent Developments

7.4 Novartis AG

7.4.1 Novartis AG Profile

7.4.2 Novartis AG Main Business

7.4.3 Novartis AG Anti-Infective Drugs Products, Services and Solutions

7.4.4 Novartis AG Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.4.5 Novartis AG Recent Developments

7.5 Gilead Sciences

7.5.1 Gilead Sciences Profile

7.5.2 Gilead Sciences Main Business

7.5.3 Gilead Sciences Anti-Infective Drugs Products, Services and Solutions

7.5.4 Gilead Sciences Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.5.5 Gilead Sciences Recent Developments

7.6 Abbott

7.6.1 Abbott Profile

7.6.2 Abbott Main Business

7.6.3 Abbott Anti-Infective Drugs Products, Services and Solutions

7.6.4 Abbott Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.6.5 Abbott Recent Developments

7.7 Sanofi-Aventis

7.7.1 Sanofi-Aventis Profile

7.7.2 Sanofi-Aventis Main Business

7.7.3 Sanofi-Aventis Anti-Infective Drugs Products, Services and Solutions

7.7.4 Sanofi-Aventis Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.7.5 Sanofi-Aventis Recent Developments

7.8 Bristol-Myers Squibb

7.8.1 Bristol-Myers Squibb Profile

7.8.2 Bristol-Myers Squibb Main Business

7.8.3 Bristol-Myers Squibb Anti-Infective Drugs Products, Services and Solutions

7.8.4 Bristol-Myers Squibb Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.8.5 Bristol-Myers Squibb Recent Developments

7.9 Johnson

7.9.1 Johnson Profile

7.9.2 Johnson Main Business

7.9.3 Johnson Anti-Infective Drugs Products, Services and Solutions

7.9.4 Johnson Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.9.5 Johnson Recent Developments

7.10 Roche Pharma AG

7.10.1 Roche Pharma AG Profile

7.10.2 Roche Pharma AG Main Business

7.10.3 Roche Pharma AG Anti-Infective Drugs Products, Services and Solutions

7.10.4 Roche Pharma AG Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.10.5 Roche Pharma AG Recent Developments

7.11 Nanosphere

7.11.1 Nanosphere Profile

7.11.2 Nanosphere Main Business

7.11.3 Nanosphere Anti-Infective Drugs Products, Services and Solutions

7.11.4 Nanosphere Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.11.5 Nanosphere Recent Developments

7.12 NanoViricides

7.12.1 NanoViricides Profile

7.12.2 NanoViricides Main Business

7.12.3 NanoViricides Anti-Infective Drugs Products, Services and Solutions

7.12.4 NanoViricides Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.12.5 NanoViricides Recent Developments

7.13 Novabay Pharmaceuticals

7.13.1 Novabay Pharmaceuticals Profile

7.13.2 Novabay Pharmaceuticals Main Business

7.13.3 Novabay Pharmaceuticals Anti-Infective Drugs Products, Services and Solutions

7.13.4 Novabay Pharmaceuticals Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.13.5 Novabay Pharmaceuticals Recent Developments

7.14 Obetech

7.14.1 Obetech Profile

7.14.2 Obetech Main Business

7.14.3 Obetech Anti-Infective Drugs Products, Services and Solutions

7.14.4 Obetech Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.14.5 Obetech Recent Developments

7.15 Optimer Pharmaceuticals

7.15.1 Optimer Pharmaceuticals Profile

7.15.2 Optimer Pharmaceuticals Main Business

7.15.3 Optimer Pharmaceuticals Anti-Infective Drugs Products, Services and Solutions

7.15.4 Optimer Pharmaceuticals Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.15.5 Optimer Pharmaceuticals Recent Developments

7.16 Basilea Pharmaceutica AG

7.16.1 Basilea Pharmaceutica AG Profile

7.16.2 Basilea Pharmaceutica AG Main Business

7.16.3 Basilea Pharmaceutica AG Anti-Infective Drugs Products, Services and Solutions

7.16.4 Basilea Pharmaceutica AG Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.16.5 Basilea Pharmaceutica AG Recent Developments

7.17 Daiichi Sankyo

7.17.1 Daiichi Sankyo Profile

7.17.2 Daiichi Sankyo Main Business

7.17.3 Daiichi Sankyo Anti-Infective Drugs Products, Services and Solutions

7.17.4 Daiichi Sankyo Anti-Infective Drugs Revenue (US$ Million) & (2019-2024)

7.17.5 Daiichi Sankyo Recent Developments

8 Industry Chain Analysis

8.1 Anti-Infective Drugs Industrial Chain

8.2 Anti-Infective Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Anti-Infective Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Anti-Infective Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Anti-Infective Drugs Market Trends

Table 2. Anti-Infective Drugs Market Drivers & Opportunity

Table 3. Anti-Infective Drugs Market Challenges

Table 4. Anti-Infective Drugs Market Restraints

Table 5. Global Anti-Infective Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Anti-Infective Drugs Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Anti-Infective Drugs Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Anti-Infective Drugs Product Type

Table 9. Key Companies Time to Begin Mass Production of Anti-Infective Drugs

Table 10. Global Anti-Infective Drugs Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Drugs as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Anti-Infective Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Anti-Infective Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Anti-Infective Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Anti-Infective Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Anti-Infective Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Anti-Infective Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Anti-Infective Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Anti-Infective Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Anti-Infective Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Anti-Infective Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Anti-Infective Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Anti-Infective Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Anti-Infective Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Anti-Infective Drugs Sales Value by Region (2019-2024) & (%)

Table 27. Global Anti-Infective Drugs Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Anti-Infective Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Anti-Infective Drugs Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Anti-Infective Drugs Sales Value, (2025-2030) & (US$ Million)

Table 31. GlaxoSmithKline Basic Information List

Table 32. GlaxoSmithKline Description and Business Overview

Table 33. GlaxoSmithKline Anti-Infective Drugs Products, Services and Solutions

Table 34. Revenue (US$ Million) in Anti-Infective Drugs Business of GlaxoSmithKline (2019-2024)

Table 35. GlaxoSmithKline Recent Developments

Table 36. Merck Basic Information List

Table 37. Merck Description and Business Overview

Table 38. Merck Anti-Infective Drugs Products, Services and Solutions

Table 39. Revenue (US$ Million) in Anti-Infective Drugs Business of Merck (2019-2024)

Table 40. Merck Recent Developments

Table 41. Pfizer Basic Information List

Table 42. Pfizer Description and Business Overview

Table 43. Pfizer Anti-Infective Drugs Products, Services and Solutions

Table 44. Revenue (US$ Million) in Anti-Infective Drugs Business of Pfizer (2019-2024)

Table 45. Pfizer Recent Developments

Table 46. Novartis AG Basic Information List

Table 47. Novartis AG Description and Business Overview

Table 48. Novartis AG Anti-Infective Drugs Products, Services and Solutions

Table 49. Revenue (US$ Million) in Anti-Infective Drugs Business of Novartis AG (2019-2024)

Table 50. Novartis AG Recent Developments

Table 51. Gilead Sciences Basic Information List

Table 52. Gilead Sciences Description and Business Overview

Table 53. Gilead Sciences Anti-Infective Drugs Products, Services and Solutions

Table 54. Revenue (US$ Million) in Anti-Infective Drugs Business of Gilead Sciences (2019-2024)

Table 55. Gilead Sciences Recent Developments

Table 56. Abbott Basic Information List

Table 57. Abbott Description and Business Overview

Table 58. Abbott Anti-Infective Drugs Products, Services and Solutions

Table 59. Revenue (US$ Million) in Anti-Infective Drugs Business of Abbott (2019-2024)

Table 60. Abbott Recent Developments

Table 61. Sanofi-Aventis Basic Information List

Table 62. Sanofi-Aventis Description and Business Overview

Table 63. Sanofi-Aventis Anti-Infective Drugs Products, Services and Solutions

Table 64. Revenue (US$ Million) in Anti-Infective Drugs Business of Sanofi-Aventis (2019-2024)

Table 65. Sanofi-Aventis Recent Developments

Table 66. Bristol-Myers Squibb Basic Information List

Table 67. Bristol-Myers Squibb Description and Business Overview

Table 68. Bristol-Myers Squibb Anti-Infective Drugs Products, Services and Solutions

Table 69. Revenue (US$ Million) in Anti-Infective Drugs Business of Bristol-Myers Squibb (2019-2024)

Table 70. Bristol-Myers Squibb Recent Developments

Table 71. Johnson Basic Information List

Table 72. Johnson Description and Business Overview

Table 73. Johnson Anti-Infective Drugs Products, Services and Solutions

Table 74. Revenue (US$ Million) in Anti-Infective Drugs Business of Johnson (2019-2024)

Table 75. Johnson Recent Developments

Table 76. Roche Pharma AG Basic Information List

Table 77. Roche Pharma AG Description and Business Overview

Table 78. Roche Pharma AG Anti-Infective Drugs Products, Services and Solutions

Table 79. Revenue (US$ Million) in Anti-Infective Drugs Business of Roche Pharma AG (2019-2024)

Table 80. Roche Pharma AG Recent Developments

Table 81. Nanosphere Basic Information List

Table 82. Nanosphere Description and Business Overview

Table 83. Nanosphere Anti-Infective Drugs Products, Services and Solutions

Table 84. Revenue (US$ Million) in Anti-Infective Drugs Business of Nanosphere (2019-2024)

Table 85. Nanosphere Recent Developments

Table 86. NanoViricides Basic Information List

Table 87. NanoViricides Description and Business Overview

Table 88. NanoViricides Anti-Infective Drugs Products, Services and Solutions

Table 89. Revenue (US$ Million) in Anti-Infective Drugs Business of NanoViricides (2019-2024)

Table 90. NanoViricides Recent Developments

Table 91. Novabay Pharmaceuticals Basic Information List

Table 92. Novabay Pharmaceuticals Description and Business Overview

Table 93. Novabay Pharmaceuticals Anti-Infective Drugs Products, Services and Solutions

Table 94. Revenue (US$ Million) in Anti-Infective Drugs Business of Novabay Pharmaceuticals (2019-2024)

Table 95. Novabay Pharmaceuticals Recent Developments

Table 96. Obetech Basic Information List

Table 97. Obetech Description and Business Overview

Table 98. Obetech Anti-Infective Drugs Products, Services and Solutions

Table 99. Revenue (US$ Million) in Anti-Infective Drugs Business of Obetech (2019-2024)

Table 100. Obetech Recent Developments

Table 101. Optimer Pharmaceuticals Basic Information List

Table 102. Optimer Pharmaceuticals Description and Business Overview

Table 103. Optimer Pharmaceuticals Anti-Infective Drugs Products, Services and Solutions

Table 104. Revenue (US$ Million) in Anti-Infective Drugs Business of Optimer Pharmaceuticals (2019-2024)

Table 105. Optimer Pharmaceuticals Recent Developments

Table 106. Basilea Pharmaceutica AG Basic Information List

Table 107. Basilea Pharmaceutica AG Description and Business Overview

Table 108. Basilea Pharmaceutica AG Anti-Infective Drugs Products, Services and Solutions

Table 109. Revenue (US$ Million) in Anti-Infective Drugs Business of Basilea Pharmaceutica AG (2019-2024)

Table 110. Basilea Pharmaceutica AG Recent Developments

Table 111. Daiichi Sankyo Basic Information List

Table 112. Daiichi Sankyo Description and Business Overview

Table 113. Daiichi Sankyo Anti-Infective Drugs Products, Services and Solutions

Table 114. Revenue (US$ Million) in Anti-Infective Drugs Business of Daiichi Sankyo (2019-2024)

Table 115. Daiichi Sankyo Recent Developments

Table 116. Key Raw Materials Lists

Table 117. Raw Materials Key Suppliers Lists

Table 118. Anti-Infective Drugs Downstream Customers

Table 119. Anti-Infective Drugs Distributors List

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

Table 123. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Anti-Infective Drugs Product Picture

Figure 2. Global Anti-Infective Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Anti-Infective Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Anti-Infective Drugs Report Years Considered

Figure 5. Global Anti-Infective Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Infective Drugs Revenue in 2023

Figure 7. Anti-Infective Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. OTC Picture

Figure 9. Rx Drugs Picture

Figure 10. Global Anti-Infective Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Anti-Infective Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Hospital

Figure 13. Product Picture of Drugs Store

Figure 14. Product Picture of Other

Figure 15. Global Anti-Infective Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Anti-Infective Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 17. North America Anti-Infective Drugs Sales Value (2019-2030) & (US$ Million)

Figure 18. North America Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030

Figure 19. Europe Anti-Infective Drugs Sales Value (2019-2030) & (US$ Million)

Figure 20. Europe Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030

Figure 21. Asia Pacific Anti-Infective Drugs Sales Value (2019-2030) & (US$ Million)

Figure 22. Asia Pacific Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030

Figure 23. South America Anti-Infective Drugs Sales Value (2019-2030) & (US$ Million)

Figure 24. South America Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030

Figure 25. Middle East & Africa Anti-Infective Drugs Sales Value (2019-2030) & (US$ Million)

Figure 26. Middle East & Africa Anti-Infective Drugs Sales Value by Country (%), 2023 VS 2030

Figure 27. Key Countries/Regions Anti-Infective Drugs Sales Value (%), (2019-2030)

Figure 28. United States Anti-Infective Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 29. United States Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030

Figure 30. United States Anti-Infective Drugs Sales Value by Application (%), 2023 VS 2030

Figure 31. Europe Anti-Infective Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 32. Europe Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030

Figure 33. Europe Anti-Infective Drugs Sales Value by Application (%), 2023 VS 2030

Figure 34. China Anti-Infective Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 35. China Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030

Figure 36. China Anti-Infective Drugs Sales Value by Application (%), 2023 VS 2030

Figure 37. Japan Anti-Infective Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 38. Japan Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030

Figure 39. Japan Anti-Infective Drugs Sales Value by Application (%), 2023 VS 2030

Figure 40. South Korea Anti-Infective Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 41. South Korea Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030

Figure 42. South Korea Anti-Infective Drugs Sales Value by Application (%), 2023 VS 2030

Figure 43. Southeast Asia Anti-Infective Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030

Figure 45. Southeast Asia Anti-Infective Drugs Sales Value by Application (%), 2023 VS 2030

Figure 46. India Anti-Infective Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 47. India Anti-Infective Drugs Sales Value by Type (%), 2023 VS 2030

Figure 48. India Anti-Infective Drugs Sales Value by Application (%), 2023 VS 2030

Figure 49. Anti-Infective Drugs Industrial Chain

Figure 50. Anti-Infective Drugs Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Anti-Infective Drugs market size from 2024 to 2030? zhanKai

The annual compound growth rate of the global Anti-Infective Drugs market is 3.4% 2024 to 2030.

Which region is expected to have the highest market share? shouQi

What was the global market size of Anti-Infective Drugs in 2030? shouQi

What was the global market size of Anti-Infective Drugs in 2024? shouQi

Which companies rank high in the global Anti-Infective Drugs market? shouQi

Related Reports

Anti-Infective Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Anti-Infective Drugs was estimated to be worth US$ 236500 million in 2025 and is projected to reach US$ 297880 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 140
USD 3950.00
(Single User License)
Global Anti-Infective Drugs Market Research Report 2026
The global Anti-Infective Drugs market was valued at US$ 236500 million in 2025 and is anticipated to reach US$ 297880 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 124
USD 2900.00
(Single User License)
Global Anti-Infective Drugs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Anti-Infective Drugs market size was US$ 229480 million in 2024 and is forecast to a readjusted size of US$ 289030 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 107
USD 4250.00
(Single User License)
Anti-Infective Drugs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Anti-Infective Drugs was estimated to be worth US$ 229480 million in 2024 and is forecast to a readjusted size of US$ 289030 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 124
USD 3950.00
(Single User License)
Global Anti-Infective Drugs Market Research Report 2025
The global market for Anti-Infective Drugs was valued at US$ 229480 million in the year 2024 and is projected to reach a revised size of US$ 289030 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published Date: 2025-02-27
Pages: 100
USD 2900.00
(Single User License)
Global Anti-Infective Drugs Market Insights, Forecast to 2030
Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
Published Date: 2024-04-25
Pages: 118
USD 4900.00
(Single User License)
Global Anti-Infective Drugs Market Research Report 2024
Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
Published Date: 2024-01-05
Pages: 94
USD 2900.00
(Single User License)

Anti-Infective Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Anti-Infective Drugs was estimated to be worth US$ 236500 million in 2025 and is projected to reach US$ 297880 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-07-15
Pages: 140
USD 3950.00 (Single User License)
Global Anti-Infective Drugs Market Research Report 2026
The global Anti-Infective Drugs market was valued at US$ 236500 million in 2025 and is anticipated to reach US$ 297880 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-04-27
Pages: 124
USD 2900.00 (Single User License)
Global Anti-Infective Drugs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Anti-Infective Drugs market size was US$ 229480 million in 2024 and is forecast to a readjusted size of US$ 289030 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 107
USD 4250.00 (Single User License)
Anti-Infective Drugs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Anti-Infective Drugs was estimated to be worth US$ 229480 million in 2024 and is forecast to a readjusted size of US$ 289030 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 124
USD 3950.00 (Single User License)
Global Anti-Infective Drugs Market Research Report 2025
The global market for Anti-Infective Drugs was valued at US$ 229480 million in the year 2024 and is projected to reach a revised size of US$ 289030 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published: 2025-02-27
Pages: 100
USD 2900.00 (Single User License)
Global Anti-Infective Drugs Market Insights, Forecast to 2030
Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
Published: 2024-04-25
Pages: 118
USD 4900.00 (Single User License)
Global Anti-Infective Drugs Market Research Report 2024
Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
Published: 2024-01-05
Pages: 94
USD 2900.00 (Single User License)